AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Engineered Respiratory Syncytial Viruses with Control of Cell-to-Cell Virus Transmission for Enhanced Safety of Live Virus Vaccines

Summary

OSU researchers have developed a method to control the rate of cell-to-celltransmission of human RSV, making it possible to tailor vaccines to thestrength each person needs for maximum protection without side effects. The method also allows for the creation of anon-functional RSV which could be used for immunocompromised patients whorequire more stringent safety conditions. The vaccine created from this method would be easy to produce sincethere is no need to for weakened RSV.

Technology Benefits

Virus cell to cell transmission can be blocked entirely or fine-tuned to different levels Improved vaccine safety Higher antigen production, recognition, and efficacy Easier production than attenuated viruses Controlled spread of virus without negative side effects

Technology Application

Prevention of human RSV outbreaks

Detailed Technology Description

None

Country/Region

USA

For more information, please click Here